INCREASED EXPRESSION OF CARDIOTROPHIN-1
IN CARDIOMYOPATHY PATIENTS
Sharif S1,*, Saleem A1, Naz S1, Rashid F1, Iqtedar M2, Kaleem A2, Latif A1
*Corresponding Author: Dr. Saima Sharif, Department of Zoology, Lahore College for Women
University, Jail Road, Lahore, Pakistan. Tel: +92-333-409-2232. Fax: +92-042-9920-3077. E-mail:
saimasharif04@ gmail.com
page: 21
|
|
REFERENCES
1. Colucci WS, Braunwald E. Heart failure: Cardiac
function and dysfunction. In: Colucci WS, Editor.
Atlas of Heart Diseases, 4th ed. Philadelphia, PA,
USA: Blackwell Science. 1995: 128-142.
2. Maron BJ, Towbi, JA, Thiene G, Antzelevitch C,
Corrado D, Arnett D, et al. Contemporary definitions
and classification of the cardiomyopathies: An
American Heart Association Scientific Statement
from the Council on Clinical Cardiology, Heart
Failure and Transplantation Committee; Quality
of Care and Outcomes Research and Functional
Genomics and Translational Biology Interdisciplinary
Working Groups; and Council on Epidemiology and
Prevention. Circulation. 2006; 113(14): 1807-1816.
3. Rosamond W, Flegal K, Furie K, Go A, Greenlund K,
Haase N, et al.; American Heart Association Statistics
Committee and Stroke Statistics Subcommittee. Heart
disease and stroke statistics--2008 update: A report
from the American Heart Association Statistics
Committee and Stroke Statistics Subcommittee.
Circulation. 2008; 117(4): e25-e146.
4. Hershberger RE, Lindenfeld J, Mestroni, L, Seidman,
CE, Taylor MR, Towbin JA; Heart Failure Society of
America. Genetic evaluation of cardiomyopathy--A
Heart Failure Society of America practice guideline.
J Card Fail 2009; 15(2): 83-97.
5. Weigner M, Morgan JP. The causes of dilated cardiomyopathy.
UpToDate. 2007; 15(3): 1-10.
6. Grenier MA, Osganian SK, Cox GF, Towbin JA,
Colan SD, Lurie PR, et al. Design and implementation
of the North American pediatric cardiomyopathy
registry. Am Heart J. 2000; 139(2 Pt 3): s86-s95.
7. Watanabe T, Konii H, Sato K. Emerging roles of
cardiotrophin-1 in the pathogenesis and biomarker
of atherosclerosis. J. 2018; 1(1): 94-105.
8. Abdul-Ghani M, Suen C, Jiang B, Deng Y, Wedrick
JJ, Putinski C, et al. Cardiotrophin 1 stimulates beneficial
myogenic and vascular remodeling of the heart.
Cell Res. 2017; 27(10): 1195-1215.
9. Konii H, Sato K, Kikuchi S, Okiyama H, Watanabe R,
Hasegawa A, et al. Stimulatory effects of cardiotrophin
1 on atheroscheloris. Hypertension. 2013; 62(5):
942-950.
10. Chomczynski P, Mackey K. Short technical reports.
Modificatin of the TRI reagent procedure for isolation
of RNA from polysaccharide- and proteoglycan-rich
sources. Biotechniques. 1995; 19(6): 942-945.
11. Geisterfer-Lowrance AA, Kass S, Tanigawa G,
Vosberg HP, McKenna W, Seidman CE, et al. A molecular
basis for familial hypertrophic cardiomyopathy:
A cardiac myosin heavy chain gene missense
mutation. Cell. 1999; 62(5): 999-1006.
12. Thomas DE, Wheeler R, Yousef ZR, Masami ND. The
role of echocardiography in guiding management in
dilated cardiomyopathy. Eur J Echocardiogr. 2009;
10(8): 15-21.
13. Miura K, Nakagawa H, Morikawa Y, Sasayama S,
Matsumori A, Hasegawa K, et al. Epidemiology of
idiopathic cardiomyopathy in Japan: Results from a
nationwide survey. Heart. 2002; 87(2): 126-130. 14. Jougasaki M, Tachibana I, Luchner A, Leskinen H,
Redfield MM, Burnett JC Jr. Augmented cardiac
cardio-trophin-1 in experimental congestive heart
failure. Circulation. 2000; 101(1): 14-17.
15. Freed DH, Cunnington RH, Dangerfield AL, Sutton
JS, Dixon IMC. Emerging evidence for the role of
cardiotrophin-1 in cardiac repair in the infarcted heart.
Cardiovasc Res. 2005; 65(4): 782-792.
16. Natal C, Antonia Fortuño M, Restituto P, Bazán A,
Colina I, Díez J, et al. Cardiotrophin-1 is expressed
in adipose tissue and upregulated in the metabolic
syndrome. Am J Physiol Endocrinol Metab. 2008;
294(1): 52-60.
17. Tsutamoto T, Wada A, Maeda K, Mabuchi N, Hayashi
M, Tsutsui T, et al. Relationship between plasma level
of cardiotrophin-1 and left ventricular mass index
in patients with dilated cardiomyopathy. J Am Coll
Cardiol. 2001; 38(5): 1485-90.
|
|
|
|
 |
Number 27
VOL. 27 (2), 2024 |
Number 27
VOL. 27 (1), 2024 |
Number 26
Number 26 VOL. 26(2), 2023 All in one |
Number 26
VOL. 26(2), 2023 |
Number 26
VOL. 26, 2023 Supplement |
Number 26
VOL. 26(1), 2023 |
Number 25
VOL. 25(2), 2022 |
Number 25
VOL. 25 (1), 2022 |
Number 24
VOL. 24(2), 2021 |
Number 24
VOL. 24(1), 2021 |
Number 23
VOL. 23(2), 2020 |
Number 22
VOL. 22(2), 2019 |
Number 22
VOL. 22(1), 2019 |
Number 22
VOL. 22, 2019 Supplement |
Number 21
VOL. 21(2), 2018 |
Number 21
VOL. 21 (1), 2018 |
Number 21
VOL. 21, 2018 Supplement |
Number 20
VOL. 20 (2), 2017 |
Number 20
VOL. 20 (1), 2017 |
Number 19
VOL. 19 (2), 2016 |
Number 19
VOL. 19 (1), 2016 |
Number 18
VOL. 18 (2), 2015 |
Number 18
VOL. 18 (1), 2015 |
Number 17
VOL. 17 (2), 2014 |
Number 17
VOL. 17 (1), 2014 |
Number 16
VOL. 16 (2), 2013 |
Number 16
VOL. 16 (1), 2013 |
Number 15
VOL. 15 (2), 2012 |
Number 15
VOL. 15, 2012 Supplement |
Number 15
Vol. 15 (1), 2012 |
Number 14
14 - Vol. 14 (2), 2011 |
Number 14
The 9th Balkan Congress of Medical Genetics |
Number 14
14 - Vol. 14 (1), 2011 |
Number 13
Vol. 13 (2), 2010 |
Number 13
Vol.13 (1), 2010 |
Number 12
Vol.12 (2), 2009 |
Number 12
Vol.12 (1), 2009 |
Number 11
Vol.11 (2),2008 |
Number 11
Vol.11 (1),2008 |
Number 10
Vol.10 (2), 2007 |
Number 10
10 (1),2007 |
Number 9
1&2, 2006 |
Number 9
3&4, 2006 |
Number 8
1&2, 2005 |
Number 8
3&4, 2004 |
Number 7
1&2, 2004 |
Number 6
3&4, 2003 |
Number 6
1&2, 2003 |
Number 5
3&4, 2002 |
Number 5
1&2, 2002 |
Number 4
Vol.3 (4), 2000 |
Number 4
Vol.2 (4), 1999 |
Number 4
Vol.1 (4), 1998 |
Number 4
3&4, 2001 |
Number 4
1&2, 2001 |
Number 3
Vol.3 (3), 2000 |
Number 3
Vol.2 (3), 1999 |
Number 3
Vol.1 (3), 1998 |
Number 2
Vol.3(2), 2000 |
Number 2
Vol.1 (2), 1998 |
Number 2
Vol.2 (2), 1999 |
Number 1
Vol.3 (1), 2000 |
Number 1
Vol.2 (1), 1999 |
Number 1
Vol.1 (1), 1998 |
|
|
